These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7833114)
1. In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. Villa R; Zaffaroni N; Orlandi L; Bearzatto A; Costa A; Silvestrini R Eur J Cancer; 1994; 30A(10):1534-40. PubMed ID: 7833114 [TBL] [Abstract][Full Text] [Related]
2. Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells. Silvestrini R; Gornati D; Zaffaroni N; Bearzatto A; De Marco C Breast Cancer Res Treat; 1997 Jan; 42(2):103-12. PubMed ID: 9138599 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line. Floridi A; Gentile PF; Bruno T; Fanciulli M; Paggi MG; Zeuli M; Benassi M Anticancer Res; 1991; 11(2):789-92. PubMed ID: 1648334 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of antiproliferative drug activity by lonidamine in hepatocellular carcinoma cells. Ricotti L; Tesei A; De Paola F; Milandri C; Amadori D; Frassineti GL; Ulivi P; Zoli W J Chemother; 2003 Oct; 15(5):480-7. PubMed ID: 14598941 [TBL] [Abstract][Full Text] [Related]
5. Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis. Orlandi L; Zaffaroni N; Bearzatto A; Villa R; De Marco C; Silvestrini R Int J Cancer; 1998 Oct; 78(3):377-84. PubMed ID: 9766575 [TBL] [Abstract][Full Text] [Related]
6. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro. Rosbe KW; Brann TW; Holden SA; Teicher BA; Frei E Cancer Chemother Pharmacol; 1989; 25(1):32-6. PubMed ID: 2590999 [TBL] [Abstract][Full Text] [Related]
7. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117 [TBL] [Abstract][Full Text] [Related]
8. In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines. Savini S; Zoli W; Nanni O; Volpi A; Frassineti GL; Magni E; Flamigni A; Amadori A; Amadori D Breast Cancer Res Treat; 1992; 24(1):27-34. PubMed ID: 1463869 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model. Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108 [TBL] [Abstract][Full Text] [Related]
10. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation. Mitchell RB; Moschel RC; Dolan ME Cancer Res; 1992 Mar; 52(5):1171-5. PubMed ID: 1737376 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro. Ning SC; Hahn GM Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227 [TBL] [Abstract][Full Text] [Related]
12. In vitro potentiation by lonidamine of the sc-RIP saporin 6 effect in a human metastatic breast cancer cell line. Roncuzzi L; Zoli W; Bajorko P; Gasperi-Campani A Anticancer Res; 1995; 15(3):773-6. PubMed ID: 7645957 [TBL] [Abstract][Full Text] [Related]
13. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity. Marathi UK; Dolan ME; Erickson LC Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells. Gu B; DeAngelis LM Anticancer Drugs; 2005 Feb; 16(2):167-74. PubMed ID: 15655414 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells. Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of photodynamic therapy by mitomycin C in cultured human colon adenocarcinoma cells. Ma LW; Moan J; Berg K; Peng Q; Steen HB Radiat Res; 1993 Apr; 134(1):22-8. PubMed ID: 8475251 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents. Villa R; Gornati D; Zaffaroni N; Veneroni S; Bidoli P; Severini A Anticancer Res; 1997; 17(2A):961-8. PubMed ID: 9137435 [TBL] [Abstract][Full Text] [Related]
18. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU. Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of cisplatin cytotoxicity by lonidamine in primary cultures of human ovarian cancer. Orlandi L; Zaffaroni N; Gornati D; Veneroni S; Silvestrini R Anticancer Res; 1994; 14(3A):1161-4. PubMed ID: 8074467 [TBL] [Abstract][Full Text] [Related]
20. Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone. Gerson SL; Zborowska E; Norton K; Gordon NH; Willson JK Biochem Pharmacol; 1993 Jan; 45(2):483-91. PubMed ID: 8435098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]